Eisbach Bio GmbH
PrivateLast Round
Grant
Nov 26, 2024
Total Funding Raised
$22.02M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eisbach Bio GmbH is a biotechnology company that develops novel drugs targeting molecular vulnerabilities in cancer genomes using its proprietary allosteric platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eisbach Bio GmbH Comparables
Compare Eisbach Bio GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOMA Therapeutics | 83% | |
| STORM Therapeutics | 79% | |
| Breakpoint Therapeutics | 77% | |
Eisbach Bio GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 26, 2024 | ||||
| VC Round | Mar 21, 2024 | ||||
| Grant | Nov 3, 2021 | ||||
| Grant | Jul 7, 2021 | ||||
| Accelerator | Jun 26, 2019 |
Key People
Founding team and executive leadership
Eisbach Bio GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| EIT Health | Accelerator |
| The University of Texas MD Anderson Cancer Center | VC Round |
| Cancer Focus Fund | VC Round |
| Bavarian State Ministry of Economic Affairs, Regional Development and Energy | Grant |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 69% MoM, from 727 to 1.2K.
- May 19, 2026
Monthly visitors grew 78% MoM.
Eisbach Bio GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Eisbach Bio GmbH's valuation, stock price, and market status.